ConductScience.org, home

Paper338308

Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension.

Planz G and 5 others. Eur J Clin Pharmacol, 1977. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension. Papers, record 338308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/338308

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.11
iCite
Revised in PubMed
2026-10-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Planz GG
2Gierlichs HWH W
3Hawlina AA
4Planz RR
5Stephany WW
6Rahn KHK H

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BenserazideMajor topic
Blood PressureMajor topic
HydrazinesMajor topic
HypertensionMajor topic
MethyldopaMajor topic
Adult
Clinical Trials as Topic
Double-Blind Method
Drug Interactions
Female
Humans
Male
Middle Aged
Placebos

Source PubMed

Download CSV of topics

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114163994THE METABOLISM OF METHYLDOPA IN HYPERTENSIVE HUMAN SUBJECTS.J Pharmacol Exp Ther1964https://conductscience.org/library/papers/14163994PubMed
214068757STUDIES ON THE METABOLISM AND MECHANISM OF ACTION OF METHYLDOPA.Circulation1963https://conductscience.org/library/papers/14068757PubMed
35819569Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.Acta Pharmacol Toxicol (Copenh)1969https://conductscience.org/library/papers/5819569PubMed
44646774The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects.Biochem J1972https://conductscience.org/library/papers/4646774PubMed
54397178Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.J Pharm Pharmacol1971https://conductscience.org/library/papers/4397178PubMed
64402836Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats.J Pharm Pharmacol1972https://conductscience.org/library/papers/4402836PubMed
714017032A new inhibitor of decarboxylase of aromatic amino acids.Experientia1962https://conductscience.org/library/papers/14017032PubMed
84390126Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine.J Pharm Pharmacol1969https://conductscience.org/library/papers/4390126PubMed
95767016Drug-induced changes of extracerebral dopa metabolism in man.Arch Neurol1969https://conductscience.org/library/papers/5767016PubMed
1014155155REDUCTION OF THE CENTRAL EFFECTS OF TRYPTOPHAN BY A DECARBOXYLASE INHIBITOR.Clin Pharmacol Ther1964https://conductscience.org/library/papers/14155155PubMed
11338308Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension.Eur J Clin Pharmacol1977https://conductscience.org/library/papers/338308PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
338308Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension.Eur J Clin Pharmacol1977https://conductscience.org/library/papers/338308

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/338308

GET https://conductscience.org/api/papers/v1/338308/authors